Skip to content
lsd.com

Virginia

Psychedelic trials in Virginia

7 registered trials has a study site in Virginia, and 1 is recruiting now.

7
Trials with a site here
1
Recruiting
4
Facilities

Open now

Recruiting in this state

TrialStatusPhaseSubstanceSites
Psilocybin for Prolonged Grief DisorderNCT06724289 · University of VirginiaRecruitingEarly Phase 1psilocybin1

Facilities

Where the research happens in Virginia

FacilityCityTrials
University of VirginiaCharlottesville1
University of Virginia Center for Psychiatric Clinical ResearchCharlottesville1
Salem VA Medical Center, Salem, VASalem1
Alexander T. Augusta Military Medical Center (ATAMMC):Fort Belvoir1

Stay told

When a trial opens in Virginia

Research alerts

Get a notification when a trial for trials in Virginia starts recruiting

This registry is rebuilt every day. If no trial is recruiting for you today, that can change within weeks.

This form sends your email address and the topic of this page to Brevo, our email provider, which stores them on servers in the European Union. We never sell that address, never share it with anyone, and never use it for advertising. One email deletes it. What is held, and where.

All trials

Every trial with a Virginia site

TrialStatusPhaseSubstanceSites
Psilocybin for Prolonged Grief DisorderNCT06724289 · University of VirginiaRecruitingEarly Phase 1psilocybin1
A Study of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant DepressionNCT04599855 · Janssen Research & Development, LLCCompletedPhase 4ketamine54
VA Aripiprazole vs Esketamine for Treatment Resistant DepressionNCT05554627 · VA Office of Research and DevelopmentWithdrawnPhase 4ketamine26
A Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Participants With Treatment-resistant DepressionNCT02422186 · Janssen Research & Development, LLCCompletedPhase 3ketamine69
A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant DepressionNCT02493868 · Janssen Research & Development, LLCCompletedPhase 3ketamine155
A Long-term Safety Study of Esketamine Nasal Spray in Treatment-resistant DepressionNCT02782104 · Janssen Research & Development, LLCCompletedPhase 3ketamine173
Department of Defense PTSD Adaptive Platform Trial - Intervention D - SLS-002NCT06816433 · Global Coalition for Adaptive ResearchSuspendedPhase 2ketamine9

Site locations from ClinicalTrials.gov API v2, data build 2026-08-25.

Elsewhere

Other states